WebApr 30, 2014 · To determine the maximum tolerated dose (MTD) of STI571, docetaxel, and cisplatin, when administered in combination for the treatment of patients with chemo-naïve recurrent and metastatic (stage IV) NSCLC. Phase 1 - Maximum Tolerated Dose (MTD) of Docetaxel and Cisplatin [ Time Frame: After cycle 1, day 22 ] ... WebOct 1, 2005 · Cisplatin was administered at 75 mg/m2 (for levels 1 and 2) but was then reduced to 60 mg/m2 (level 1A). At every level, a cohort of three patients, which could be expanded to six patients, was studied. Maximum-tolerated dose (MTD) was determined based on the dose-limiting toxicity (DLT) in the first cycle.
Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an
WebDec 1, 2024 · A cisplatin-derived Pt (IV) prodrug was conjugated to 2- (1-methyl-1,2,3,6-tetrahydropyridin-4-yl)propenamide to target GBM mitochondria, showing promising anti-tumoral effects in vitro and in vivo [ 31 ]. Low intensity pulsed ultrasound increases carboplatin delivery across the BBB by 4.2-fold and increased survival in GBM murine … WebOct 7, 2024 · Cisplatin is one of the most widely used chemotherapeutic drugs in the treatment of a wide range of pediatric and adult malignances. However, it has various … port richey county police
Cisplatin (Cisplatin Injection): Uses, Dosage, Side Effects ... - RxList
WebJun 16, 2024 · The DD regimen was defined as the combination of 5 mg/kg paclitaxel and 3 mg/kg cisplatin, while the MTD regimen consisted of higher dosages of 12 mg/kg paclitaxel and 7 mg/kg cisplatin. These results clearly showed that DD chemotherapy profoundly reduced the number of MDSCs, more significantly than mice in the MTD group. ... WebApr 19, 2024 · RT, despite the advanced disease, survival was comparable to the combination of cisplatin Vet. Sci. 2024 , 9 , 196 9 of 47 and piroxicam as well as intralesional cisplatin implant, of which the ... WebJun 15, 2024 · Bi-weekly injections of Pt(IV)-M13 were well-tolerated in nude mice to at least 15mg/kg, three times the reported cisplatin MTD. Finally, Pt(IV)-M13 treatment increased survival in a murine glioblastoma xenograft model (median survival= 33 days for Pt(IV)-M13 vs. 22.5 days for cisplatin and 24 days Pt(IV) alone. Elevated γH2AX foci were ... iron pigs baseball team apparel